Unknown NA INTERVENTIONAL 2-arm
NCT05507372
Treatment for Post Acute COVID-19 Syndrome
Sponsor: Applied Biology, Inc.
Conditions
Tinnitus, Subjective
Interventions
Pimozide 1 MG
Updated 3 times since 2022 Last updated: Aug 18, 2022 Started: Oct 1, 2022 Primary completion: Jun 1, 2023 Completion: Dec 1, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT05507372, this NA trial focuses on Tinnitus, Subjective and remains ongoing. Sponsored by Applied Biology, Inc., it has been updated 3 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
3 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
Status: Not Yet Recruiting → Unknown
-
Jul 2024 — Sep 2024 [monthly]
Not Yet Recruiting NA
-
Sep 2022 — Jul 2024 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Applied Biology, Inc.
- Jupiter Wellness, Inc.
Data source: Applied Biology, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.